P.M. van der Kraan

16.8k citations

257 papers · 13.2k indexed · 1 hit paper · h-index 64

Rheumatology top 0.02%
Molecular Biology top 1%
Surgery top 1%
Pharmacology top 0.2%
Cancer Research top 1%

Co-authors: Wim B. van den Berg E.N. Blaney Davidson Henk M. van Beuningen E.L. Vitters Arjen B. Blom A. van Caam Peter L. E. M. van Lent Pieter Buma
Topics: Osteoarthritis Treatment and Mechanisms (170 papers)Inflammatory mediators and NSAID effects (65 papers)TGF-β signaling in diseases (43 papers)
Cited by: Rheumatology Urology Immunology and Allergy
Journals: Journal of NeuroscienceSHILAP Revista de lepidopterologíaThe Journal of Immunology
Partner nations: Netherlands United States Germany

In The Last Decade

P.M. van der Kraan

252 papers receiving 13.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Chondrocyte hypertrophy and osteoarthritis: role in initiation and progression of cartilage degeneration?

2011 526 citations P.M. van der Kraan, Wim B. van den Berg Osteoarthritis and Cartilage profile →

Peers

Countries citing papers authored by P.M. van der Kraan

Since Specialization

Citations

This map shows the geographic impact of P.M. van der Kraan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P.M. van der Kraan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P.M. van der Kraan more than expected).

Fields of papers citing papers by P.M. van der Kraan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P.M. van der Kraan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P.M. van der Kraan. The network helps show where P.M. van der Kraan may publish in the future.

Co-authorship network of co-authors of P.M. van der Kraan

This figure shows the co-authorship network connecting the top 25 collaborators of P.M. van der Kraan. A scholar is included among the top collaborators of P.M. van der Kraan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P.M. van der Kraan. P.M. van der Kraan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Collagen binding properties separate two functionally distinct subpopulations of milk extracellular vesicles regarding bone regenerative capacity 2025 ·Materials Today Bio ·Peng Wang,Yang Zhang,Onno J. Arntz,Marina C. Oliveira,(unknown),(unknown),P.M. van der Kraan,Jeroen J.J.P. van den Beucken,Fons A. J. van de Loo	0
2	Systemic sclerosis-associated pulmonary arterial hypertension is characterized by a distinct peripheral T helper cell profile 2024 ·Lara D. Veeken ·(unknown),(unknown),A. van Caam,Jacqueline L Vos,E.L. Vitters,(unknown),Sander I. van Leuven,Marije I. Koenders,P.M. van der Kraan,Hans J. P. M. Koenen,Ruben L. Smeets,Robin Nijveldt,Madelon C Vonk,Rogier M. Thurlings	1
3	Growth factors that drive aggrecan synthesis in healthy articular cartilage. Role for transforming growth factor-β? 2024 ·SHILAP Revista de lepidopterología ·P.M. van der Kraan,A. van Caam,E.N. Blaney Davidson,Martijn H. J. van den Bosch,Fons A. J. van de Loo	0
4	CD64 as novel molecular imaging marker for the characterization of synovitis in rheumatoid arthritis 2023 ·Arthritis Research & Therapy ·(unknown),Irene Di Ceglie,(unknown),Arjen B. Blom,Desirée L. Bos,Thomas Vogl,Sander W. Tas,(unknown),Mats Bergström,(unknown),P.M. van der Kraan,Peter Laverman,Marije I. Koenders,P.L. van Lent,Martijn H. J. van den Bosch	5
5	Inflammation in osteoarthritis: Our view on its presence and involvement in disease development over the years 2023 ·Osteoarthritis and Cartilage ·Martijn H. J. van den Bosch,Arjen B. Blom,P.M. van der Kraan	37
6	Gas6/Axl Axis Activation Dampens the Inflammatory Response in Osteoarthritic Fibroblast-like Synoviocytes and Synovial Explants 2023 ·Pharmaceuticals ·Juliana P. Vago,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Martijn H. J. van den Bosch,P.M. van der Kraan,Marije I. Koenders,Flávio A. Amaral,Fons A. J. van de Loo	6
7	Intensive cholesterol-lowering treatment reduces synovial inflammation during early collagenase-induced osteoarthritis, but not pathology at end-stage disease in female dyslipidemic E3L.CETP mice 2023 ·Osteoarthritis and Cartilage ·(unknown),Arjen B. Blom,Irene Di Ceglie,Birgitte Walgreen,M.M. Helsen,A. Sloëtjes,Thomas Vogl,Johannes Roth,(unknown),Elsbet Pieterman,P. Hans,P.M. van der Kraan,Peter L. E. M. van Lent,Martijn H. J. van den Bosch	3
8	Identification of CD64 as a marker for the destructive potential of synovitis in osteoarthritis 2023 ·Lara D. Veeken ·(unknown),(unknown),Irene Di Ceglie,(unknown),(unknown),(unknown),Peter L. E. M. van Lent,P.M. van der Kraan,Arjen B. Blom,Martijn H. J. van den Bosch	2
9	Inhibition of TLR4 signalling to dampen joint inflammation in osteoarthritis 2023 ·Lara D. Veeken ·(unknown),Peter L. E. M. van Lent,P.M. van der Kraan,Arjen B. Blom,Kimberly M. Bonger,Martijn H. J. van den Bosch	14
10	Mechanical stress and inflammation have opposite effects on Wnt signaling in human chondrocytes 2023 ·Journal of Orthopaedic Research® ·(unknown),Arjen B. Blom,Rob G. H. H. Nelissen,(unknown),P.M. van der Kraan,Ingrid Meulenbelt,Martijn H. J. van den Bosch,Y.F. Ramos	2
11	CCN4/WISP1 Promotes Migration of Human Primary Osteoarthritic Chondrocytes 2022 ·Cartilage ·(unknown),Arjen B. Blom,(unknown),Rob G. H. H. Nelissen,(unknown),P.M. van der Kraan,Ingrid Meulenbelt,Y.F. Ramos,Martijn H. J. van den Bosch	4
12	Increased IL-6 receptor expression and signaling in ageing cartilage can be explained by loss of TGF-β-mediated IL-6 receptor suppression 2021 ·Osteoarthritis and Cartilage ·(unknown),(unknown),A. van Caam,M. van de Laar,Henk M. van Beuningen,Marije I. Koenders,Peter L. E. M. van Lent,P.M. van der Kraan,Fons A. J. van de Loo,E.N. Blaney Davidson	13
13	Nox2 Deficiency Reduces Cartilage Damage and Ectopic Bone Formation in an Experimental Model for Osteoarthritis 2021 ·Antioxidants ·(unknown),Irene Di Ceglie,(unknown),Birgitte Walgreen,Monique M. Helsen,A. Sloëtjes,Marije I. Koenders,Fons A. J. van de Loo,Johannes Roth,Thomas Vogl,P.M. van der Kraan,Arjen B. Blom,Peter L. E. M. van Lent,Martijn H. J. van den Bosch	8
14	Selective Increment of Synovial Soluble TYRO3 Correlates with Disease Severity and Joint Inflammation in Patients with Rheumatoid Arthritis 2020 ·Journal of Immunology Research ·(unknown),Juliana P. Vago,(unknown),Rogier M. Thurlings,Marije I. Koenders,Peter L. E. M. van Lent,P.M. van der Kraan,Flávio A. Amaral,Fons A. J. van de Loo	9
15	Tyro3/Axl/Mertk-deficient mice develop bone marrow edema which is an early pathological marker in rheumatoid arthritis 2018 ·PLoS ONE ·(unknown),Marije I. Koenders,Peter L. E. M. van Lent,P.M. van der Kraan,Fons A. J. van de Loo	20
16	Treatment of collagenase-induced osteoarthritis with a viral vector encoding TSG-6 results in ectopic bone formation 2018 ·PeerJ ·Mathijs G A Broeren,Irene Di Ceglie,Miranda B. Bennink,Peter L. E. M. van Lent,Wim B. van den Berg,Marije I. Koenders,E.N. Blaney Davidson,P.M. van der Kraan,Fons A. J. van de Loo	6
17	The role of NOX2-derived reactive oxygen species in collagenase-induced osteoarthritis 2018 ·Osteoarthritis and Cartilage ·(unknown),(unknown),Birgitte Walgreen,M.M. Helsen,A. Sloëtjes,Niels A. J. Cremers,Marije I. Koenders,Fons A. J. van de Loo,Johannes Roth,Thomas Vogl,Arjen B. Blom,P.M. van der Kraan,Peter L. E. M. van Lent,Martijn H. J. van den Bosch	16
18	Human osteoarthritic synovium impacts chondrogenic differentiation of mesenchymal stem cells via macrophage polarisation state 2014 ·Osteoarthritis and Cartilage ·Niamh Fahy,(unknown),Johannes Lehmann,W. Wei,Nienke Grotenhuis,Eric Farrell,P.M. van der Kraan,Mary Murphy,Y.M. Bastiaansen-Jenniskens,Gerjo J.V.M. van Osch	220
19	Phenotypic differences in murine chondrocyte cell lines derived from mature articular cartilage 2002 ·Osteoarthritis and Cartilage ·Henk M. van Beuningen,Reinout Stoop,Pieter Buma,Nozomi Takahashi,P.M. van der Kraan,Wim B. van den Berg	37
20	Tissue engeneering, cells, scaffolds, and growth factors. 2001 ·Clinical Orthopaedics and Related Research ·Wim B. van den Berg,P.M. van der Kraan,Alwin Scharstuhl,Henk M. van Beuningen	1

About P.M. van der Kraan

P.M. van der Kraan is a scholar working on Rheumatology, Immunology and Allergy and Pharmacology, having authored 257 papers that have together received 13.2k indexed citations. Recurring topics across this work include Osteoarthritis Treatment and Mechanisms (170 papers), Inflammatory mediators and NSAID effects (65 papers) and TGF-β signaling in diseases (43 papers). The work is most often cited by research in Rheumatology (8.7k citations), Urology (1.4k citations) and Immunology and Allergy (999 citations). P.M. van der Kraan has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Wim B. van den Berg, E.N. Blaney Davidson, Henk M. van Beuningen, E.L. Vitters, Arjen B. Blom, A. van Caam, Peter L. E. M. van Lent, Pieter Buma, Harrie L. Glansbeek and Marije I. Koenders. Their work appears in journals such as Journal of Neuroscience, SHILAP Revista de lepidopterología and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact